Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

BIOLOPTIM: implementation of therapeutic drug monitoring for biologicals in psoriasis and hidradenitis supparativa

Outputs and Outcomes

Publications

Ixekizumab trough concentrations in psoriasis : paving the way towards personalised therapy : a cohort study

Lisa SchotsRani SoenenDebby ThomasAnnelies StockmanErwin DreesenAnke EylenboschJo Lambert

A2 Journal Article in JEADV CLINICAL PRACTICE

Blocking interleukin-17 in psoriasis : real-world experience from the PsoPlus cohort

Lisa SchotsRani SoenenBrigitte BlanquartDebby ThomasJo Lambert

A1 Journal Article in JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Therapeutic drug monitoring in psoriasis : from empiric dose adaptations to guided clinical decision making

Rani SoenenJo LambertPaul DeclerckLynda GrineDebby Thomas

Promising tools to facilitate the implementation of TDM of biologics in clinical practice

Rani SoenenChristophe StoveAlessio CapobiancoHanne De SchutterMarie DobbelaereTahmina MahjorMerel FollensJo LambertLynda Grine

A1 Journal Article in JOURNAL OF CLINICAL MEDICINE

Therapeutic drug monitoring in dermatology : the way towards dose optimization of secukinumab in chronic plaque psoriasis

Rani SoenenZhigang WangLynda GrineErwin DreesenLisa SchotsEls BrouwersPaul DeclerckDebby ThomasJo Lambert

A1 Journal Article in CLINICAL AND EXPERIMENTAL DERMATOLOGY

Effectiveness and tolerability of guselkumab in patients with psoriasis : a longitudinal Belgian retrospective multicenter study

Pierre-Dominique GhislainValérie FaillaJo LambertRani SoenenLynda GrineJulio TannousFrançoise GuiotFabienne WillaertHugues FierensMark VandaeleHugo BoonenJulie SaerensVéronique MeulemanAnnelies StockmanArno BelpaireSandra SwimbergheLinda TemmermanSam DekeyserJean-Michel LambertVirginie de SchaetzenMichel de la BrassinneFarida Benhadou et al.

A2 Journal Article in JAAD INTERNATIONAL

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis

Nathalie Van den BergheAurélie TruffotMiet PeetersGriet CompernolleEls BrouwersRani SoenenLynda GrineAnn GilsMaya Imbrechts

A1 Journal Article in JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Real‐life effectiveness and short‐term (16‐week) tolerance of guselkumab for psoriasis : a Belgian retrospective multicentre study

F. BenhadouPD. GhislainF. GuiotF. WillaertV. Del MarmolJo LambertRani SoenenH. FierensM. de la Brassinne

A1 Journal Article in JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Defining a minimal effective serum trough concentration of secukinumab in psoriasis : a step toward personalized therapy

Rani SoenenEvelyn MeulewaeterLynda GrineNathalie Van den BergheEls BrouwersReinhart SpeeckaertSven LanssensLinda TemmermanJo LambertAnn Gils

A1 Journal Article in JOURNAL OF INVESTIGATIVE DERMATOLOGY

Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Rani SoenenEvelyn MeulewaeterLynda GrineLinda TemmermanSven LanssensEls BrouwersNathalie Van den BergheReinhart SpeeckaertJo LambertAnn Gils

Developing a therapeutic window for secukinumab in psoriasis : a step towards personalized therapy

Rani SoenenEvelyn MeulewaeterLynda GrineNathalie Van den BergheEls BrouwersReinhart SpeeckaertSven LanssensLinda TemmermanJo LambertAnn Gils